ARCHIVES

Study: Angiopoietin-2 Levels May Predict Lenvatinib Response

This article is from The Cancer Letter archive.

Vol. 37 No. 10 | October 31, 2014

Download PDF Visit The Full Archive

Related Articles

NCAB Disproves W. Virginia Construction Grant, Okays Funding Three New, Three Carryover Awards

May 24, 1985

Imbruvica Improves PFS, OS In Phase III CLL Study

December 26, 2014

Data Presented At Scientific Meetings Can Have Impact On Patient Treatment

March 31, 2006

Duke Officials Decline To Provide Details Of Probe

July 23, 2010

In Brief: Parkinson To Leave CTEP For Novartis; FTC To Permit Sandoz, Ciba-Geigy Merger

January 10, 1997

DCPC Board Okays Start of Low Fat High Risk Breast Cancer Study, Delays Stage 2 Trial

February 1, 1985